PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Secures $2.1 Billion Deal for Obesity Pill Development

Novo Nordisk has signed a $2.1 billion agreement aimed at developing more effective oral medications for obesity.

25 Feb, 13:00 — 25 Feb, 13:00
PostShare

Sources

Showing 1 of 1 sources
forbes42d ago

Novo Nordisk Inks $2.1 Billion Deal To Develop Better Obesity Pills - Forbes

Novo Nordisk Inks $2.1 Billion Deal To Develop Better Obesity Pills  Forbes

Read full article →

Related Stories

Obituary: Santero Kujala, Respected Health Policy Influencer

8m ago

Helsinki Foster Mother Shares Experience Raising Nine Children

8m ago

Prosecutors Seek Tiger Woods' Medication Records After DUI Arrest

21m ago

Parents summoned to meeting nearly a month after school bus accident

28m ago